Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $19.4M | $45.6M | $67.1M | $70.7M | $86.0M | $72.6M | $65.3M | $75.5M | $80.7M | $112.3M | $127.1M | $95.6M | $143.6M | $150.7M | $206.9M | $241.7M | $346.2M | $661.8M | $585.9M | $593.4M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, West Pharmaceutical Services, Inc.'s last 12-month Net Income is $499.6M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, West Pharmaceutical Services, Inc.'s Net Income growth was (10.7%). The average annual Net Income growth rates for West Pharmaceutical Services, Inc. have been 5.7% over the past three years, 16.8% over the past five years.
Over the last year, West Pharmaceutical Services, Inc.'s Net Income growth was (10.7%), which is lower than industry growth of 8.8%. It indicates that West Pharmaceutical Services, Inc.'s Net Income growth is Bad.